Rhythm Pharmaceuticals Inc (RYTM): Next-Year EPS Estimate 76.52%
As of 2026-06-04, Rhythm Pharmaceuticals Inc (RYTM) has a next-year EPS growth estimate of 76.52%.
On 2026-05-11, analyst consensus for RYTM's next-year EPS growth shifted from 77.50% to 76.52% — a negative change of 0.98 percentage points. The revised estimate has been sustained across 19 subsequent trading sessions. Current-year growth is projected at -1.25%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 76.52%
- EPS growth this year
- -1.25%
- EPS next quarter (est)
- -$0.81
- Last price
- $87.61
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 76.52% | -1.25% | -$0.81 | $87.61 |
| 2026-06-03 | 76.52% | -1.25% | -$0.81 | $84.71 |
| 2026-06-02 | 76.52% | -1.25% | -$0.81 | $84.35 |
| 2026-06-01 | 76.52% | -1.25% | -$0.81 | $87.87 |
| 2026-05-31 | 76.52% | -1.25% | -$0.81 | $88.32 |
| 2026-05-28 | 76.52% | -1.25% | -$0.81 | $92.98 |
| 2026-05-27 | 76.52% | -1.25% | -$0.81 | $91.42 |
| 2026-05-26 | 76.52% | -1.25% | -$0.81 | $89.82 |
| 2026-05-25 | 76.52% | -1.25% | -$0.81 | $87.84 |
| 2026-05-24 | 76.52% | -1.25% | -$0.81 | $87.84 |
| 2026-05-21 | 76.52% | -1.25% | -$0.81 | $90.19 |
| 2026-05-20 | 76.52% | -1.25% | -$0.81 | $90.64 |
| 2026-05-19 | 76.52% | -1.25% | -$0.81 | $87.21 |
| 2026-05-18 | 76.52% | -1.25% | -$0.81 | $86.84 |
| 2026-05-17 | 76.52% | -1.25% | -$0.81 | $90.52 |
| 2026-05-14 | 76.52% | -1.25% | -$0.81 | $93.63 |
| 2026-05-13 | 76.52% | -1.25% | -$0.81 | $95.38 |
| 2026-05-12 | 76.52% | -1.25% | -$0.81 | $91.31 |
| 2026-05-11 | 76.52% | -1.25% | -$0.81 | $87.39 |
| 2026-05-10 | 77.50% | -0.39% | -$0.81 | $94.17 |
| 2026-05-07 | 79.57% | 0.50% | -$0.81 | $96.23 |
| 2026-05-06 | 79.17% | 0.70% | -$0.81 | $96.61 |
| 2026-05-05 | 80.17% | 0.98% | -$0.80 | $92.31 |
| 2026-05-04 | 77.27% | 0.85% | -$0.82 | $85.58 |
| 2026-05-03 | 77.27% | 0.85% | -$0.82 | $81.81 |
| 2026-04-30 | 82.70% | 0.85% | -$0.82 | $81.36 |
| 2026-04-29 | 82.70% | 0.85% | -$0.82 | $82.12 |
| 2026-04-28 | 82.70% | 0.85% | -$0.82 | $84.18 |
| 2026-04-27 | 82.70% | 0.85% | -$0.82 | $85.20 |
| 2026-04-26 | 82.70% | 0.85% | -$0.82 | $85.70 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Rhythm Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Rhythm Pharmaceuticals Inc (RYTM) has a next-year EPS growth estimate of 76.52%, based on analyst consensus.
When was the latest EPS estimate revision for RYTM?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 77.50% to 76.52%.
What sector and industry does Rhythm Pharmaceuticals Inc belong to?▾
Rhythm Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. RYTM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Rhythm Pharmaceuticals Inc (RYTM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports